Clinical Trial: A Study of AT-02 in Subjects With Systemic Amyloidosis.
Study Status: Completed
Recruit Status: RECRUITING
Condition: Amyloidosis; Systemic
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of AT-02
Brief Summary:
This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02.AT-02 is an investigational medicinal product being developed to treat systemic amyloidosis.
Read more